Antisuperbugs: 3 million euros for technological innovation in the prevention of resistance of microorganisms to antibiotics

The healthcare market is one of the areas with the greatest purchasing impact in the public and private sector in Spain with a business turnover of 71 billion euros annually. It is a very complex market where the formulas used for purchasing both consumer goods and drugs, and services depend on the centres themselves. However, they also depend on the local regulations of suppliers, autonomous regions as well as state and community legislation. Read more

Antisuperbugs Prior Information Notice Published in TED

On 11/10/2017 the prior information notice for the project ANTI-SUPERBUGS has been published in the European Tenders Electronic Daily. The ANTISUPERBUGS pre-commercial procurement aims to improve the quality of care processes in hospital and the reduction of both the costs and the collateral effects provoked by Multi-Drug Resistant Organisms (MDROs, otherwise known as Superbugs) and other Health Associated Infections (HAIs) pathogens, through the development and testing of prototypes of devices and ICT services that can:

(1) test non-invasively for the presence of MDROs and other pathogens, and

(2) provide continuous information and remote alerts to health professionals on environmental contamination by MDROs — and other pathogens — on high contact surfaces, applicable to existing healthcare environments.

More details here.
Stay tuned!​

ANTISUPERBUGS: A Pre-commercial Procurement (PCP) developing ICT solutions for detecting resistant microorganisms in health-care environments

Day: May 4th 2017

Schedule: 13:00–14:15h

Where: Healthio Meeting, Fira Barcelona (Recinte Montjuïc), Av. Reina Maria Cristina, s/n, Barcelona

Anti-SUPERBugs PCP project wants to mobilize public and private purchasers and networks of users in the field of health-care associated infections to put the joint & direct procurement process in action, by addressing the current innovation gap with demand-driven incentives for further R&D (Research & Development) in the field of antimicrobial resistance surveillance.

Event page: HEALTHIO Meeting